Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Cash flows from operating activities    
Net loss $ (462,476) $ (118,649)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 10,697 9,383
Amortization of deferred contract acquisition costs 19,904 28,478
Amortization of deferred loan cost 199 0
Net amortization of premium on marketable securities 1,391 0
Loss on fixed asset disposal 772 0
Stock-based compensation expense 438,551 65,794
Amortization of operating lease right-of-use assets 6,013 5,522
(Benefit from) provision for bad debt (194) 1,382
Provision for uncertain tax position 822 0
Deferred income taxes (357) 68
Changes in operating assets and liabilities:    
Accounts receivable (27,028) (34,191)
Contract assets (29,994) (18,459)
Deferred contract acquisition costs (80,720) (28,885)
Prepaid expenses and other assets (2,295) 208
Accounts payable 17,549 1,983
Accrued expense and other liabilities 17,756 8,009
Accrued compensation and employee benefits (822) 24,233
Operating lease liabilities, net (5,261) (6,075)
Deferred revenue 46,544 72,197
Net cash (used in) provided by operating activities (48,949) 10,998
Cash flows from investing activities    
Purchases of marketable securities (161,214) 0
Sales of marketable securities 89,383 0
Maturities of marketable securities 58,109 0
Purchases of property and equipment (5,719) (989)
Capitalization of software development costs (2,950) 0
Payment related to business acquisition, net of cash acquired (5,498) (19,690)
Purchases of intangible assets (1,231) 0
Net cash used in investing activities (29,120) (20,679)
Cash flows from financing activities    
Proceeds from initial public offering, net of underwriting discounts and commissions 692,369 0
Payments of initial public offering costs (3,734) 0
Proceeds from issuance of convertible preferred stock 750,000 225,903
Payments of issuance costs for convertible preferred stock (164) (324)
Proceeds from exercise of stock options 9,687 19,837
Payments of tax withholdings on net settlement of equity awards (10,300) 0
Net receipts of tax withholdings on sell-to-cover equity award transactions 20,418 0
Proceeds from employee stock purchase plan contributions 13,766 0
Proceeds from credit facility 0 78,587
Repayments of credit facility 0 (78,587)
Payment of deferred loan costs related to senior secured credit facility 0 (808)
Net cash provided by financing activities 1,472,042 244,608
Effect of exchange rate changes 11,254 (8,402)
Net increase in cash, cash equivalents and restricted cash 1,405,227 226,525
Cash, cash equivalents and restricted cash - beginning of period 371,190 234,131
Cash, cash equivalents and restricted cash - end of period 1,776,417 460,656
Supplemental disclosure of cash flow information    
Cash paid for interest 512 1,510
Cash paid for income taxes 6,680 2,642
Supplemental disclosure of non-cash investing and financing activities    
Stock-based compensation capitalized for software development 4,487 0
Value of shares issued in payment of business acquisition 30,467 0
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options 2,723 1,544
Tax withholdings on net settlement of restricted stock units, accrued and unpaid $ 445 $ 0